Knowledge Tree
Relations (1)
Facts (12)
Sources
Ancient Roots of Today's Emerging Renaissance in ... link.springer.com 4 facts
referenceSchmidt (2016) conducted a randomized controlled trial demonstrating that psilocybin treatment leads to rapid and sustained symptom reduction in patients with life-threatening cancer suffering from anxiety and depression.
referenceCharles A. Grob, Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam L. Halberstadt, and George R. Greer published the 'Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer' in the Archives of General Psychiatry in 2011.
referenceRoland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P. Cosimano, and Margaret A. Klinedinst published the study 'Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial' in the Journal of Psychopharmacology in 2016.
claimFor psilocybin users, the psychological and emotional state during the four weeks prior to a psychedelic episode is a critical determinant in whether the user experiences severe anxiety, known as a 'bad trip,' or a positive, 'spiritual' encounter.
Psychedelics, Sociality, and Human Evolution frontiersin.org 2 facts
referenceGoldberg et al. (2020a) conducted a meta-analysis finding that psilocybin has experimental effects on symptoms of anxiety and depression.
measurementPatients with depression, anxiety, or post-traumatic stress disorder (n=24) showed decreased neuroticism and increased extraversion sustained at a 3-month follow-up after psilocybin administration, according to Erritzoe et al. (2018).
Altered States of Consciousness, Psychedelics - Academia.edu academia.edu 1 fact
claimResearch into the therapeutic applications of psilocybin has been ongoing for decades, with recent studies indicating positive results for treating depression, anxiety, and addiction.
Psychedelic Drugs News - ScienceDaily sciencedaily.com 1 fact
claimPsilocybin, the active ingredient in magic mushrooms, is being investigated for its potential to treat depression and anxiety in cancer patients.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua 1 fact
claimStephen Ross et al. conducted a randomized controlled trial showing rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer, published in the Journal of Psychopharmacology, volume 30, page 1165.
Classification Schemes of Altered States of Consciousness - ORBi orbi.uliege.be 1 fact
claimRoss et al. (2016) conducted a randomized controlled trial demonstrating that psilocybin treatment leads to rapid and sustained symptom reduction for anxiety and depression in patients with life-threatening cancer.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 1 fact
referenceRoss, Bossis, Guss, Agin-Liebes, Malone, Cohen, et al. published 'Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial' in the Journal of Psychopharmacology in 2016 (doi: 10.1177/0269881116675512).
Published Studies — Johns Hopkins Center for Psychedelic and ... hopkinspsychedelic.org 1 fact
claimPsilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer, as demonstrated in a randomized double-blind trial.